Get the Stockscreener App
2.48
16.78%
-0.50
After Hours:
2.51
0.03
+1.21%
Prokidney Corp stock is traded at $2.48, with a volume of 8.25M.
It is down -16.78% in the last 24 hours and up +10.71% over the past month.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
See More
Previous Close:
$2.98
Open:
$3
24h Volume:
8.25M
Relative Volume:
0.64
Market Cap:
$334.78M
Revenue:
-
Net Income/Loss:
$-35.47M
P/E Ratio:
-4.3509
EPS:
-0.57
Net Cash Flow:
$-124.27M
1W Performance:
+10.22%
1M Performance:
+10.71%
6M Performance:
+150.58%
1Y Performance:
+4.20%
1-Day Range:
$2.3712
$3.05
1-Week Range:
$2.12
$3.05
52-Week Range:
$0.4603
$7.13
Prokidney Corp Stock (PROK) Company Profile
Name
Prokidney Corp
Sector
Industry
Phone
336-999-7028
Address
2000 FRONTIS PLAZA BLVD., WINSTON-SALEM
Compare PROK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PROK
Prokidney Corp
|
2.48 | 291.59M | 0 | -35.47M | -124.27M | -0.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Prokidney Corp Stock (PROK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-30-25 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-30-24 | Initiated | JP Morgan | Neutral |
| Sep-10-24 | Initiated | Guggenheim | Buy |
| Mar-07-24 | Resumed | Morgan Stanley | Equal-Weight |
| Jan-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-25-23 | Initiated | BTIG Research | Buy |
| Dec-21-22 | Initiated | Jefferies | Buy |
| Nov-10-22 | Initiated | Morgan Stanley | Equal-Weight |
| Oct-18-22 | Initiated | UBS | Buy |
| Oct-14-22 | Initiated | Citigroup | Buy |
| Sep-23-22 | Initiated | BofA Securities | Buy |
| Sep-02-22 | Initiated | Evercore ISI | Outperform |
View All
Prokidney Corp Stock (PROK) Latest News
ProKidney Leads Our Trio Of Promising Penny Stocks - Yahoo Finance
Nuveen LLC Acquires Shares of 266,366 ProKidney Corp. $PROK - MarketBeat
Chartists See Breakout Potential in ProKidney Corp.Earnings Performance Report & Verified Momentum Stock Watchlist - beatles.ru
Bollinger Band Squeeze Points to Volatility in ProKidney Corp.Weekly Stock Summary & Weekly Setup with ROI Potential - beatles.ru
ProKidney at Morgan Stanley Conference: Strategic Insights on CKD Therapy - Investing.com
ProKidney at Morgan Stanley Conference: Strategic Insights on CKD Therapy By Investing.com - Investing.com Canada
Brokerages Set ProKidney Corp. (NASDAQ:PROK) PT at $6.25 - MarketBeat
Key metrics from ProKidney Corp.’s quarterly dataJuly 2025 Review & Long Hold Capital Preservation Plans - Newser
Is ProKidney Corp. subject to activist investor interestWeekly Loss Report & Technical Confirmation Alerts - خودرو بانک
ProKidney Corp. stock volume spike explainedTrade Risk Assessment & AI Based Buy/Sell Signal Reports - Newser
Is ProKidney Corp. meeting your algorithmic filter criteriaJuly 2025 Sentiment & Community Trade Idea Sharing - Newser
ProKidney Corp. stock chart pattern explainedWeekly Stock Analysis & Capital Efficiency Focused Ideas - Newser
Market Leaders: Can ProKidney Corp. continue delivering strong returnsSwing Trade & Long-Term Growth Stock Strategies - خودرو بانک
What’s the beta of ProKidney Corp. stockJuly 2025 Retail & Stock Portfolio Risk Management - خودرو بانک
ProKidney (NASDAQ:PROK) Stock Price Down 5.6%Here's Why - MarketBeat
Is ProKidney Corp. a top pick in the sectorJuly 2025 Update & Reliable Entry Point Trade Alerts - خودرو بانک
How moving averages guide ProKidney Corp. trading2025 Institutional Moves & Weekly Top Performers Watchlists - Newser
Is ProKidney Corp. a potential multi baggerM&A Rumor & Safe Capital Growth Trade Ideas - خودرو بانک
What is the PEG ratio of ProKidney Corp.July 2025 Short Interest & Trade Opportunity Analysis Reports - خودرو بانک
Candlestick signals on ProKidney Corp. stock todayJuly 2025 Spike Watch & Daily Oversold Bounce Ideas - Newser
Will ProKidney Corp. bounce back from current supportJuly 2025 Technicals & Low Risk Entry Point Guides - Newser
Is ProKidney Corp. a good ESG investmentAnalyst Downgrade & Verified Entry Point Signals - خودرو بانک
Will ProKidney Corp. price bounce be sustainableWall Street Watch & Technical Entry and Exit Alerts - Newser
Can ProKidney Corp. continue delivering strong returns2025 Stock Rankings & Risk Managed Investment Signals - خودرو بانک
Combining machine learning predictions for ProKidney Corp.July 2025 Short Interest & AI Based Buy and Sell Signals - Newser
Price action breakdown for ProKidney Corp.July 2025 Sector Moves & Risk Managed Trade Strategies - Newser
Using R and stats models for ProKidney Corp. forecastingJuly 2025 Movers & Daily Stock Trend Reports - Newser
Using fundamentals and technicals on ProKidney Corp.July 2025 PostEarnings & Community Consensus Trade Alerts - Newser
What are ProKidney Corp.’s recent SEC filings showing2025 Geopolitical Influence & Short-Term High Return Ideas - خودرو بانک
ProKidney Corp. shares fall 2.12% premarket after presenting at Citi's Biopharma Summit. - AInvest
Will ProKidney Corp. rebound enough to break evenJuly 2025 Earnings & Daily Market Momentum Tracking - Newser
Analyzing ProKidney Corp. with risk reward ratio chartsJuly 2025 Technicals & Verified Momentum Stock Alerts - Newser
Has ProKidney Corp. found a price floor2025 Institutional Moves & Community Verified Swing Trade Signals - Newser
Custom strategy builders for tracking ProKidney Corp.Weekly Market Report & Safe Capital Preservation Plans - Newser
Is ProKidney Corp. forming bullish engulfing patternsJuly 2025 Drop Watch & Reliable Breakout Stock Forecasts - خودرو بانک
Multi factor analysis applied to ProKidney Corp.2025 Top Gainers & Verified Momentum Stock Alerts - Newser
Regression analysis insights on ProKidney Corp. performanceProduct Launch & Accurate Buy Signal Alerts - Newser
ProKidney Corp. shares fall 1.69% after-hours following presentation at Citi's Biopharma Summit. - AInvest
Can ProKidney Corp. deliver consistent EPS growthWeekly Profit Recap & Low Volatility Stock Recommendations - خودرو بانک
ProKidney at Citi’s Biopharma Back to School Conference: CKD Therapy Progress - Investing.com
ProKidney Corp. shares rise 1.96% intraday after presenting at Citi's Biopharma back-to-school Summit. - AInvest
ProKidney Corp: Pioneering CKD Innovation in Emerging Markets - AInvest
Using data filters to optimize entry into ProKidney Corp.Weekly Gains Report & Capital Efficient Trade Techniques - Newser
Using RSI to spot recovery in ProKidney Corp.2025 Price Targets & Daily Market Momentum Tracking - Newser
Will ProKidney Corp. benefit from seasonalityWeekly Investment Summary & Accurate Entry and Exit Point Alerts - خودرو بانک
Is ProKidney Corp. forming a bullish divergenceJuly 2025 Macro Moves & Verified Swing Trading Watchlist - خودرو بانک
What moving averages say about ProKidney Corp.Portfolio Risk Summary & Pattern Based Trade Signal System - Newser
Real time breakdown of ProKidney Corp. stock performance2025 Price Momentum & Reliable Volume Spike Trade Alerts - Newser
Geopolitics Watch: Should value investors consider ProKidney Corp.Market Volume Report & Safe Capital Growth Stock Tips - خودرو بانک
Will ProKidney Corp. stock recover after recent dropTrade Volume Report & Real-Time Volume Trigger Notifications - Newser
Can ProKidney Corp. reach resistance levels soonJuly 2025 Highlights & Low Risk Profit Maximizing Plans - خودرو بانک
Prokidney Corp Stock (PROK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):